What Dose of Semaglutide is Most Effective for Weight Loss?

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain and gut, reducing hunger and slowing stomach emptying—effects that intensify as your body adjusts to higher doses. Clinical trials show that most patients achieve meaningful weight loss between 0.5 mg and 2.4 mg weekly, with the highest doses producing the greatest metabolic changes. Finding your optimal semaglutide dose requires careful monitoring and personalization, which is why PlexusDx tailors each protocol to your unique physiology.

How Semaglutide Dosing Schedules Build Over Time

Semaglutide treatment begins at a low dose and increases gradually over 16 to 20 weeks in what physicians call a titration protocol. Starting doses typically range from 0.25 mg to 0.5 mg weekly, allowing your body to adapt to the medication's appetite-suppressing and metabolic effects. Each dose increase happens about every 4 weeks, with increments of 0.25 mg, moving progressively upward until reaching your therapeutic target or until side effects plateau.

The slow increase in semaglutide dosing serves two critical purposes: it reduces nausea and gastrointestinal discomfort during the early treatment phase, and it allows your brain and metabolism time to establish new satiety signals. Most patients notice appetite reduction within the first two weeks, even at starting doses, though weight loss typically accelerates as doses climb. PlexusDx creates individualized titration schedules based on your medical history, baseline weight, and metabolic markers to optimize both safety and efficacy.

Semaglutide Dose Ranges and Weight Loss Outcomes

Research from the STEP clinical trials demonstrated that weekly semaglutide doses of 0.5 mg, 1.0 mg, and 2.4 mg produced dose-dependent weight loss, with average reductions ranging from 5% to 18% of baseline body weight over 68 weeks. Patients receiving 2.4 mg weekly experienced the largest absolute weight loss, though intermediate doses like 1.0 mg often provide sufficient metabolic benefit for many individuals while reducing the risk of severe nausea or vomiting. Individual responses vary significantly based on genetic factors, body composition, and baseline metabolic function.

The relationship between semaglutide dose and weight loss is not linear—some patients achieve their weight loss goals at lower doses and experience diminishing returns or intolerable side effects at higher levels. Others require higher doses to achieve meaningful appetite suppression and fat loss. This variability explains why personalized dosing protocols matter: a standard one-size-fits-all approach misses opportunities to optimize outcomes for your specific metabolism and genetic profile.

Personalizing Your Semaglutide Dose with Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx offers the Precision Peptide Genetic Test, $298, which maps 14 metabolic pathways across 49 peptides to reveal how your genes influence weight regulation, appetite control, and medication response. This test identifies genetic predispositions in GLP-1 signaling, insulin sensitivity, and leptin function—insights that allow your PlexusDx clinician to refine your dosing strategy for maximum effectiveness. Rather than guessing whether you need standard or higher-dose semaglutide, genetic guidance removes the guesswork and accelerates your path to the right dose.

Managing Semaglutide Dose Side Effects and Adjustments

Nausea, constipation, and reduced appetite for foods you enjoy are common during the first weeks of semaglutide therapy and often improve as your body acclimates to each new dose level. If side effects persist or worsen during titration, PlexusDx clinicians may slow the increase schedule, maintain your current dose longer before advancing, or adjust dietary habits—such as eating smaller meals or avoiding fatty or greasy foods—to minimize gastrointestinal stress. Most side effects resolve within 2 to 4 weeks of dose adjustment, allowing treatment to continue productively.

Reaching your optimal semaglutide dose sometimes means stopping the titration at 1.0 mg or 1.7 mg rather than advancing to 2.4 mg if weight loss plateaus and further increases trigger intolerable side effects. The 'most effective' dose for any individual is the highest tolerable dose that produces your goal weight loss without compromising quality of life. PlexusDx provides ongoing support and monitoring to help you navigate dose adjustments, communicate side effects clearly, and maintain safe, sustainable weight loss without unnecessary medication increases.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

Most semaglutide weight-loss programs begin at 0.25 mg or 0.5 mg injected once weekly, with increases of 0.25 mg every 4 weeks until reaching your therapeutic target or plateau.

What dose of semaglutide did the STEP trials use for weight loss?

The STEP clinical trials tested weekly semaglutide doses of 0.5 mg, 1.0 mg, and 2.4 mg over 68 weeks, showing that 2.4 mg produced the greatest average weight loss (approximately 18% of baseline body weight), though 1.0 mg and 1.7 mg often deliver sufficient results with fewer side effects for many patients.

How much does semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all commitment tiers—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible for all 50 states.

When should I stop increasing my semaglutide dose?

You should reach your optimal semaglutide dose when weight loss plateaus, side effects become intolerable, or you achieve your weight-loss goal—not necessarily at the maximum 2.4 mg dose. Many patients experience excellent results at 1.0 mg to 1.7 mg and choose to stay at those levels rather than advancing further.

How can genetic testing help me find the right semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.